| 1 |
25568846 | OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib. | 2014 Dec |
1 |
| 2 |
21663515 | Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1. | 2011 Oct |
1 |
| 3 |
18398725 | Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia. | 2008 Apr |
1 |
| 4 |
18559609 | Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications. | 2008 Jun 15 |
2 |
| 5 |
18669873 | Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia. | 2008 Oct 15 |
5 |